1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Human Microbiome Modulators Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Probiotics and Creams 1.2.3 Prebiotics and Dietary Supplements 1.2.4 Drugs 1.3 Market by Application 1.3.1 Global Human Microbiome Modulators Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Digestive Health 1.3.3 Immune Health 1.3.4 Oral Health 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Human Microbiome Modulators Market Perspective (2016-2027) 2.2 Human Microbiome Modulators Growth Trends by Regions 2.2.1 Human Microbiome Modulators Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Human Microbiome Modulators Historic Market Share by Regions (2016-2021) 2.2.3 Human Microbiome Modulators Forecasted Market Size by Regions (2022-2027) 2.3 Human Microbiome Modulators Industry Dynamic 2.3.1 Human Microbiome Modulators Market Trends 2.3.2 Human Microbiome Modulators Market Drivers 2.3.3 Human Microbiome Modulators Market Challenges 2.3.4 Human Microbiome Modulators Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Human Microbiome Modulators Players by Revenue 3.1.1 Global Top Human Microbiome Modulators Players by Revenue (2016-2021) 3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2016-2021) 3.2 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Human Microbiome Modulators Revenue 3.4 Global Human Microbiome Modulators Market Concentration Ratio 3.4.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2020 3.5 Human Microbiome Modulators Key Players Head office and Area Served 3.6 Key Players Human Microbiome Modulators Product Solution and Service 3.7 Date of Enter into Human Microbiome Modulators Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Human Microbiome Modulators Breakdown Data by Type 4.1 Global Human Microbiome Modulators Historic Market Size by Type (2016-2021) 4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2022-2027) 5 Human Microbiome Modulators Breakdown Data by Application 5.1 Global Human Microbiome Modulators Historic Market Size by Application (2016-2021) 5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Human Microbiome Modulators Market Size (2016-2027) 6.2 North America Human Microbiome Modulators Market Size by Type 6.2.1 North America Human Microbiome Modulators Market Size by Type (2016-2021) 6.2.2 North America Human Microbiome Modulators Market Size by Type (2022-2027) 6.2.3 North America Human Microbiome Modulators Market Size by Type (2016-2027) 6.3 North America Human Microbiome Modulators Market Size by Application 6.3.1 North America Human Microbiome Modulators Market Size by Application (2016-2021) 6.3.2 North America Human Microbiome Modulators Market Size by Application (2022-2027) 6.3.3 North America Human Microbiome Modulators Market Size by Application (2016-2027) 6.4 North America Human Microbiome Modulators Market Size by Country 6.4.1 North America Human Microbiome Modulators Market Size by Country (2016-2021) 6.4.2 North America Human Microbiome Modulators Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Human Microbiome Modulators Market Size (2016-2027) 7.2 Europe Human Microbiome Modulators Market Size by Type 7.2.1 Europe Human Microbiome Modulators Market Size by Type (2016-2021) 7.2.2 Europe Human Microbiome Modulators Market Size by Type (2022-2027) 7.2.3 Europe Human Microbiome Modulators Market Size by Type (2016-2027) 7.3 Europe Human Microbiome Modulators Market Size by Application 7.3.1 Europe Human Microbiome Modulators Market Size by Application (2016-2021) 7.3.2 Europe Human Microbiome Modulators Market Size by Application (2022-2027) 7.3.3 Europe Human Microbiome Modulators Market Size by Application (2016-2027) 7.4 Europe Human Microbiome Modulators Market Size by Country 7.4.1 Europe Human Microbiome Modulators Market Size by Country (2016-2021) 7.4.2 Europe Human Microbiome Modulators Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Human Microbiome Modulators Market Size (2016-2027) 8.2 Asia-Pacific Human Microbiome Modulators Market Size by Type 8.2.1 Asia-Pacific Human Microbiome Modulators Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Human Microbiome Modulators Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Human Microbiome Modulators Market Size by Type (2016-2027) 8.3 Asia-Pacific Human Microbiome Modulators Market Size by Application 8.3.1 Asia-Pacific Human Microbiome Modulators Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Human Microbiome Modulators Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Human Microbiome Modulators Market Size by Application (2016-2027) 8.4 Asia-Pacific Human Microbiome Modulators Market Size by Region 8.4.1 Asia-Pacific Human Microbiome Modulators Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Human Microbiome Modulators Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Human Microbiome Modulators Market Size (2016-2027) 9.2 Latin America Human Microbiome Modulators Market Size by Type 9.2.1 Latin America Human Microbiome Modulators Market Size by Type (2016-2021) 9.2.2 Latin America Human Microbiome Modulators Market Size by Type (2022-2027) 9.2.3 Latin America Human Microbiome Modulators Market Size by Type (2016-2027) 9.3 Latin America Human Microbiome Modulators Market Size by Application 9.3.1 Latin America Human Microbiome Modulators Market Size by Application (2016-2021) 9.3.2 Latin America Human Microbiome Modulators Market Size by Application (2022-2027) 9.3.3 Latin America Human Microbiome Modulators Market Size by Application (2016-2027) 9.4 Latin America Human Microbiome Modulators Market Size by Country 9.4.1 Latin America Human Microbiome Modulators Market Size by Country (2016-2021) 9.4.2 Latin America Human Microbiome Modulators Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Human Microbiome Modulators Market Size (2016-2027) 10.2 Middle East & Africa Human Microbiome Modulators Market Size by Type 10.2.1 Middle East & Africa Human Microbiome Modulators Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Human Microbiome Modulators Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Human Microbiome Modulators Market Size by Type (2016-2027) 10.3 Middle East & Africa Human Microbiome Modulators Market Size by Application 10.3.1 Middle East & Africa Human Microbiome Modulators Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Human Microbiome Modulators Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Human Microbiome Modulators Market Size by Application (2016-2027) 10.4 Middle East & Africa Human Microbiome Modulators Market Size by Country 10.4.1 Middle East & Africa Human Microbiome Modulators Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Human Microbiome Modulators Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer Human Microbiome Modulators Introduction 11.1.4 Bayer Revenue in Human Microbiome Modulators Business (2016-2021) 11.1.5 Bayer Recent Development 11.2 BioGaia 11.2.1 BioGaia Company Details 11.2.2 BioGaia Business Overview 11.2.3 BioGaia Human Microbiome Modulators Introduction 11.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2016-2021) 11.2.5 BioGaia Recent Development 11.3 Chr. Hansen Holding 11.3.1 Chr. Hansen Holding Company Details 11.3.2 Chr. Hansen Holding Business Overview 11.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction 11.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2016-2021) 11.3.5 Chr. Hansen Holding Recent Development 11.4 DowDuPont 11.4.1 DowDuPont Company Details 11.4.2 DowDuPont Business Overview 11.4.3 DowDuPont Human Microbiome Modulators Introduction 11.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2016-2021) 11.4.5 DowDuPont Recent Development 11.5 Ingredion 11.5.1 Ingredion Company Details 11.5.2 Ingredion Business Overview 11.5.3 Ingredion Human Microbiome Modulators Introduction 11.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2016-2021) 11.5.5 Ingredion Recent Development 11.6 ISOThrive 11.6.1 ISOThrive Company Details 11.6.2 ISOThrive Business Overview 11.6.3 ISOThrive Human Microbiome Modulators Introduction 11.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2016-2021) 11.6.5 ISOThrive Recent Development 11.7 Jarrow Formulas 11.7.1 Jarrow Formulas Company Details 11.7.2 Jarrow Formulas Business Overview 11.7.3 Jarrow Formulas Human Microbiome Modulators Introduction 11.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2016-2021) 11.7.5 Jarrow Formulas Recent Development 11.8 DSM 11.8.1 DSM Company Details 11.8.2 DSM Business Overview 11.8.3 DSM Human Microbiome Modulators Introduction 11.8.4 DSM Revenue in Human Microbiome Modulators Business (2016-2021) 11.8.5 DSM Recent Development 11.9 Lallemand 11.9.1 Lallemand Company Details 11.9.2 Lallemand Business Overview 11.9.3 Lallemand Human Microbiome Modulators Introduction 11.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2016-2021) 11.9.5 Lallemand Recent Development 11.10 Sanofi 11.10.1 Sanofi Company Details 11.10.2 Sanofi Business Overview 11.10.3 Sanofi Human Microbiome Modulators Introduction 11.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2016-2021) 11.10.5 Sanofi Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Human Microbiome Modulators Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Probiotics and Creams Table 3. Key Players of Prebiotics and Dietary Supplements Table 4. Key Players of Drugs Table 5. Global Human Microbiome Modulators Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Human Microbiome Modulators Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Human Microbiome Modulators Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Human Microbiome Modulators Market Share by Regions (2016-2021) Table 9. Global Human Microbiome Modulators Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Human Microbiome Modulators Market Share by Regions (2022-2027) Table 11. Human Microbiome Modulators Market Trends Table 12. Human Microbiome Modulators Market Drivers Table 13. Human Microbiome Modulators Market Challenges Table 14. Human Microbiome Modulators Market Restraints Table 15. Global Human Microbiome Modulators Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Human Microbiome Modulators Market Share by Players (2016-2021) Table 17. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2020) Table 18. Ranking of Global Top Human Microbiome Modulators Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Human Microbiome Modulators Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Human Microbiome Modulators Product Solution and Service Table 22. Date of Enter into Human Microbiome Modulators Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 25. Global Human Microbiome Modulators Revenue Market Share by Type (2016-2021) Table 26. Global Human Microbiome Modulators Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Human Microbiome Modulators Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Human Microbiome Modulators Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Human Microbiome Modulators Revenue Market Share by Application (2016-2021) Table 30. Global Human Microbiome Modulators Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Human Microbiome Modulators Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 33. North America Human Microbiome Modulators Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Human Microbiome Modulators Market Size by Application (2016-2021) (US$ Million) Table 35. North America Human Microbiome Modulators Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Human Microbiome Modulators Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Human Microbiome Modulators Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Human Microbiome Modulators Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Human Microbiome Modulators Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Human Microbiome Modulators Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Human Microbiome Modulators Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Human Microbiome Modulators Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Human Microbiome Modulators Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Human Microbiome Modulators Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Human Microbiome Modulators Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Human Microbiome Modulators Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Human Microbiome Modulators Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Human Microbiome Modulators Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Human Microbiome Modulators Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Human Microbiome Modulators Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Human Microbiome Modulators Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Human Microbiome Modulators Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Human Microbiome Modulators Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Human Microbiome Modulators Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Human Microbiome Modulators Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Human Microbiome Modulators Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Human Microbiome Modulators Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Human Microbiome Modulators Market Size by Country (2022-2027) & (US$ Million) Table 62. Bayer Company Details Table 63. Bayer Business Overview Table 64. Bayer Human Microbiome Modulators Product Table 65. Bayer Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 66. Bayer Recent Development Table 67. BioGaia Company Details Table 68. BioGaia Business Overview Table 69. BioGaia Human Microbiome Modulators Product Table 70. BioGaia Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 71. BioGaia Recent Development Table 72. Chr. Hansen Holding Company Details Table 73. Chr. Hansen Holding Business Overview Table 74. Chr. Hansen Holding Human Microbiome Modulators Product Table 75. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 76. Chr. Hansen Holding Recent Development Table 77. DowDuPont Company Details Table 78. DowDuPont Business Overview Table 79. DowDuPont Human Microbiome Modulators Product Table 80. DowDuPont Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 81. DowDuPont Recent Development Table 82. Ingredion Company Details Table 83. Ingredion Business Overview Table 84. Ingredion Human Microbiome Modulators Product Table 85. Ingredion Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 86. Ingredion Recent Development Table 87. ISOThrive Company Details Table 88. ISOThrive Business Overview Table 89. ISOThrive Human Microbiome Modulators Product Table 90. ISOThrive Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 91. ISOThrive Recent Development Table 92. Jarrow Formulas Company Details Table 93. Jarrow Formulas Business Overview Table 94. Jarrow Formulas Human Microbiome Modulators Product Table 95. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 96. Jarrow Formulas Recent Development Table 97. DSM Company Details Table 98. DSM Business Overview Table 99. DSM Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 100. DSM Recent Development Table 101. Lallemand Company Details Table 102. Lallemand Business Overview Table 103. Lallemand Human Microbiome Modulators Product Table 104. Lallemand Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 105. Lallemand Recent Development Table 106. Sanofi Company Details Table 107. Sanofi Business Overview Table 108. Sanofi Human Microbiome Modulators Product Table 109. Sanofi Revenue in Human Microbiome Modulators Business (2016-2021) & (US$ Million) Table 110. Sanofi Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Human Microbiome Modulators Market Share by Type: 2020 VS 2027 Figure 2. Probiotics and Creams Features Figure 3. Prebiotics and Dietary Supplements Features Figure 4. Drugs Features Figure 5. Global Human Microbiome Modulators Market Share by Application: 2020 VS 2027 Figure 6. Digestive Health Case Studies Figure 7. Immune Health Case Studies Figure 8. Oral Health Case Studies Figure 9. Others Case Studies Figure 10. Human Microbiome Modulators Report Years Considered Figure 11. Global Human Microbiome Modulators Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Human Microbiome Modulators Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Human Microbiome Modulators Market Share by Regions: 2020 VS 2027 Figure 14. Global Human Microbiome Modulators Market Share by Regions (2022-2027) Figure 15. Global Human Microbiome Modulators Market Share by Players in 2020 Figure 16. Global Top Human Microbiome Modulators Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Modulators as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Modulators Revenue in 2020 Figure 18. Global Human Microbiome Modulators Revenue Market Share by Type (2016-2021) Figure 19. Global Human Microbiome Modulators Revenue Market Share by Type (2022-2027) Figure 20. North America Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Human Microbiome Modulators Market Share by Type (2016-2027) Figure 22. North America Human Microbiome Modulators Market Share by Application (2016-2027) Figure 23. North America Human Microbiome Modulators Market Share by Country (2016-2027) Figure 24. United States Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Human Microbiome Modulators Market Share by Type (2016-2027) Figure 28. Europe Human Microbiome Modulators Market Share by Application (2016-2027) Figure 29. Europe Human Microbiome Modulators Market Share by Country (2016-2027) Figure 30. Germany Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Human Microbiome Modulators Market Share by Type (2016-2027) Figure 38. Asia-Pacific Human Microbiome Modulators Market Share by Application (2016-2027) Figure 39. Asia-Pacific Human Microbiome Modulators Market Share by Region (2016-2027) Figure 40. China Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Human Microbiome Modulators Market Share by Type (2016-2027) Figure 48. Latin America Human Microbiome Modulators Market Share by Application (2016-2027) Figure 49. Latin America Human Microbiome Modulators Market Share by Country (2016-2027) Figure 50. Mexico Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Human Microbiome Modulators Market Share by Type (2016-2027) Figure 54. Middle East & Africa Human Microbiome Modulators Market Share by Application (2016-2027) Figure 55. Middle East & Africa Human Microbiome Modulators Market Share by Country (2016-2027) Figure 56. Turkey Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Human Microbiome Modulators Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 60. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 61. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 62. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 63. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 64. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 65. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 66. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 67. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 68. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Bayer BioGaia Chr. Hansen Holding DowDuPont Ingredion ISOThrive Jarrow Formulas DSM Lallemand Sanofi